Kevin J. Bitterman
Independent DirectorDr. Kevin J. Bitterman, PhD, serves as Partner at Atlas Venture Advisors, Inc., which he joined in 2017. He serves as Independent Director at Disc Medicine, Inc. since November 2017. He also serves as Director at GRO Biosciences Inc. since July 2024, Director at Judo Bio Inc., Director at nChroma Bio, Inc., Director at Renasant Bio, Inc., Director at Kinaset Therapeutics, Inc., Director at Chroma Medicine, Inc., Secretary & Director at Mariana Oncology, Inc. since September 15, 2021, Director at Navitor Pharmaceuticals, Inc., Director at InSeal Medical Ltd., Director at ZappRx, Inc., Director at Elemera Oncology and Director at Ursa Medicines. He Founded the Remix Therapeutics, Inc. and also served as Treasurer and was its Director until September 2026. He is Co-Founder of Sirtris Pharmaceuticals, Inc. and also served as Business Development/Biology Consultant. Additionally, he is a member of the Isabella Stuart Gardner Museum Board of Trustees. Previously, Dr. Bitterman was a Partner at Polaris Growth Management, L.L.C. from 2004 to 2017, where he was a member of the healthcare team and focused on Healthcare. He served as Independent Director at Akero Therapeutics, Inc. from June 2018 to December 31, 2021, where he was also employed. He was the founding CEO and Non-Employee Director at Editas Medicine, Inc., where he was employed from June 2014 to June 15, 2018. He served as Director at KALA BIO, Inc. until May 2017. At Genocea Biosciences, Inc., he served as Director, where he was employed from August 2006 to March 6, 2017. He served as Director at Neuronetics, Inc. from May 16, 2011. He served as Director at Follica, Inc. from August 2008. He served as Director at Biolex Therapeutics, Inc. from December 2007. He was the founding CEO and Director at Visterra, Inc., which he joined in 2007. He was the founding CEO and Director at Morphic Holding, Inc. At Remix Therapeutics, Inc., he also served as Treasurer & Chairman. At Disc Medicine, Inc., he also served as President & Director. He was a Director at TARIS Biomedical LLC, a Director at Solace Pharmaceuticals, Inc. and a Board Observer of Cerulean Pharma Inc. Dr. Bitterman focuses on creating and investing in companies that translate groundbreaking science into innovative medicines. Dr. Bitterman received a B.A. in Philosophy & Biological Sciences, with highest honors, from Rutgers, The State University of New Jersey in 1999 and a Ph.D. in Genetics from Harvard Medical School in 2004.
公司職務
- 公司名稱Disc Medicine, Inc.股票代碼IRON職務Independent Director共事同僚
- DWDonald William NicholsonExecutive Chairman
- JDJohn D. QuiselCEO, President & Director
- JMJean M. FranchiChief Financial Officer
- JYJonathan YuChief Opearating Officer
- WJWilliam Jacob SavageChief Medical Officer
- BMBrian MacDonaldFounder & Chair of Scientific Advisory Board
- WRWilliam R. WhiteIndependent Director
